Original Articles and Brief Reports

Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Massachusetts General Hospital Cancer Center, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Dana-Farber Cancer Institute, Boston, MA, USA
Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Massachusetts General Hospital Cancer Center, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Beth Israel Deaconess Medical Center, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Massachusetts General Hospital Cancer Center, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Brigham and Women's Hospital, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Dana-Farber Cancer Institute, Boston, MA, USA
Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Massachusetts General Hospital Cancer Center, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Vol. 98 No. 4 (2013): April, 2013 https://doi.org/10.3324/haematol.2012.075184